Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months Duration Camille F. de Oliveira , Walter F. F. Neto , Carla P. da Silva , Ana Claudia S. Ribeiro , Livia C. Martins , Alana W. de Sousa , Maria N. O. Freitas , Jannifer O. Chiang , Franko A. Silva , Eder B. dos Santos , Daniele B. A. Medeiros , Gleiciane S. Pinheiro , Gleiciane F. Brandao , Valeria L. Carvalho , Raimunda S. S. Azevedo , Pedro F. C. Vasconcelos , Igor B. Costa , Iran B. Costa , Mirleide C. dos Santos , Luana S. Soares , Rayssa L. S. Bedran , James L. Ferreira , Alberto A. Amarilla , Naphak Modhiran , Christopher L. D. McMillan , Morgan E. Freney , David A. Muller , Daniel Watterson , Livia M. N. Casseb , Daniele F. Henriques Vaccines（2022）
Key words
COVID-19, SARS-CoV-2, CoronaVac, vaccines, antibodies
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
